Comparative tissue distributions of cadmium chloride and cadmium-based quantum dot 705 in mice: Safety implications and applications

Nanotoxicology

Volumn 5, Issue 1, 2011, Pages 91-97

  Yeh, Teng Kuang ^a   Wu, Jui Pin ^a   Chang, Louis W ^a   Tsai, Ming Hsien ^a   Chang, Wan Hsuan ^a   Tsai, Hui Ti ^a   Yang, Chung Shi ^a   Lin, Pinpin ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

cadmium; plasma; quantum dot 705; Tissue distribution

Indexed keywords

CADMIUM; CADMIUM CHLORIDE; QUANTUM DOT; QUANTUM DOT 705; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG RETENTION; IN VIVO STUDY; KIDNEY; LIVER; MALE; MONONUCLEAR PHAGOCYTE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TISSUE DISTRIBUTION;

ANIMALS; CADMIUM CHLORIDE; DIAGNOSTIC IMAGING; HAZARDOUS SUBSTANCES; KIDNEY; LIVER; MALE; METAL NANOPARTICLES; METALLOTHIONEIN; MICE; MICE, INBRED ICR; QUANTUM DOTS; TISSUE DISTRIBUTION;

ANIMALIA; MUS;

EID: 79952846226     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2010.502260     Document Type: Article

References (24)

1. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99:12617-12621.
2. Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X. 2006. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 6:669-676.
3. Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, Heine JR, Mattoussi H, Ober R, Jensen KF, Bawendi MG. 1997. (CdSe)ZnS core-shell quantum dots: Synthesis and characterization of a size series of highly luminescent nanocrystallites. J Phys Chem B 101:9463-9475. (Pubitemid 127581259)
4. Douglas SJ, Davis SS, and Illum L. 1987. Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst 3:233-261. (Pubitemid 17021225)
5. Fischer HC, Liu J, Pang KS, Chang WCW. 2006. Pharmacokinetics of nanoscale quantum dots: In vivo distribution, sequetration, and clearance in the rat. Adv Func Mater 16:1299-1305. (Pubitemid 44049451)
6. Groom AC, Schmidt EE, MacDonald IC 1991. Microcirculatory pathways and blood flow in spleen: new insights from washout kinetics, corrosion casts, and quantitative intravital videomicroscopy. Scanning Microsc 5:159-173; discussion 173-154.
7. Hardman R. 2006. A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114:165-172. (Pubitemid 43193634)
8. Klaassen CD, Liu J. 1997. Role of metallothionein in cadmiuminduced hepatotoxicity and nephrotoxicity. Drug Metab Rev 29:79-102. (Pubitemid 27293603)
9. Klaassen CD. 2008. Casarett & Doulls Toxicology: The Basic Science of Poisons. 7th ed. Columbus, OH: The McGraw-Hill Companies.
10. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, Webb WW. 2003. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300: 1434-1436. (Pubitemid 36638163)
11. Lenaerts V, Nagelkerke JF, Van Berkel TJ, Couvreur P, Grislain L, Roland M, Speiser P. 1984. In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells. J Pharm Sci 73:980-982. (Pubitemid 14084777)
12. Lim YT, Kim S, Nakayama A, Stott NE, Bawendi MG, Frangioni JV. 2003. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol Imaging 2:50-64.
13. Lin CH, Chang LW, Chang H, Yang MH, Yang CS, Lai WH, Chang WH, Lin P. 2009. The chemical fate of the Cd/Se/Te-based quantum dot 705 in the biological system: Toxicity implications. Nanotechnology 20:215101.
14. Lin P, Chen JW, Chang LW, Wu JP, Redding L, Chang H, Yeh TK, Yang CS, Tsai MH, Wang HJ, Kuo YC, Yang RS. 2008. Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice. Environ Sci Technol 42:6264-6270.
15. Liu J, Klaassen CD. 1996. Absorption and distribution of cadmium in metallothionein-I transgenic mice. Fundam Appl Toxicol 29:294-300.
16. Liu J, Liu Y, Michalska AE, Choo KH, Klaassen CD. 1996. Distribution and retention of cadmium in metallothionein I and II null mice. Toxicol Appl Pharmacol 136:260-268. (Pubitemid 26070892)
17. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. 2005. Quan-tum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4:435-446. (Pubitemid 40774047)
18. Morgan NY, English S, Chen W, Chernomordik V, Russo A, Smith PD, Gandjbakhche A. 2005. Real time in vivo non-invasive optical imaging using near-infrared fluorescent quan-tum dots. Acad Radiol 12:313-323. (Pubitemid 40353762)
19. Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627. (Pubitemid 43191298)
20. Popescu MA, Toms SA. 2006. In vivo optical imaging using quantum dots for the management of brain tumors. Expert Rev Mol Diagn 6:879-890. (Pubitemid 44904004)
21. Schultz IR, Peters EL, Newman MC. 1996. Toxicokinetics and disposition of inorganic mercury and cadmium in channel catfish after intravascular administration. Toxicol Appl Pharmacol 140:39-50. (Pubitemid 26329460)
22. Tanaka K, Min K, Onosaka S, Fukuhara C 1987. Synthesis and degradation of erythrocyte metallothionein in cadmium-administered mice. Experientia Suppl 52:525-532.
23. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. 2004. Tracking metastatic tumor cell extravasation with quantum dot nanocrys-tals and fluorescence emission-scanning microscopy. Nat Med 10:993-998. (Pubitemid 39273742)
24. Yang RS, Chang LW, Wu JP, Tsai MH, Wang HJ, Kuo YC, Yeh TK, Yang CS, Lin P. 2007. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 115:1339-1343. (Pubitemid 47471259)